HBsAg-ELISA Reagent Kit for Enzyme Immunoassay Detection of Hepatitis B Virus Surface Antigen in Human Serum (Plasma) According to TU 21.20.23-0092-18619450-2020

The HBsAg-ELISA reagent kit is designed for the enzyme immunoassay (ELISA) detection of hepatitis B virus surface antigen (HBsAg) in human serum or plasma.

Available configurations:

Kit 1 – 96 Tests

96-well microplate – 1 pc
Negative control – 1 vial (3.0 ml)
Positive control Ag+ – 1 vial (1.0 ml)
Positive control Ag++ – 1 vial (1.0 ml)
Conjugate B – 1 vial (4.0 ml)
Conjugate A concentrate – 1 vial (0.5 ml)
Conjugate A dilution buffer – 1 vial (5.0 ml)
TMB substrate solution – 1 vial (14 ml)
Wash buffer concentrate – 1 vial (22 ml)
Stop reagent – 1 vial (14 ml)
Plate sealing sheet – 2 pcs
Instructions for use – 1 pc
Quality control certificate (analytical passport) – 1 pc

Kit 2 – 192 Tests

96-well microplate – 2 pcs
Negative control – 1 vial (3.0 ml)
Positive control Ag+ – 1 vial (1.0 ml)
Positive control Ag++ – 1 vial (1.0 ml)
Conjugate B – 1 vial (8.0 ml)
Conjugate A concentrate – 1 vial (1.0 ml)
Conjugate A dilution buffer – 1 vial (10 ml)
TMB substrate solution – 1 vial (30 ml)
Wash buffer concentrate – 1 vial (50 ml)
Stop reagent – 1 vial (30 ml)
Plate sealing sheet – 4 pcs
Instructions for use – 1 pc
Quality control certificate (analytical passport) – 1 pc

Kit 5 – 480 Tests

96-well microplate – 5 pcs
Negative control – 1 vial (6.0 ml)
Positive control Ag+ – 1 vial (2.0 ml)
Positive control Ag++ – 1 vial (2.0 ml)
Conjugate B – 1 vial (20.0 ml)
Conjugate A concentrate – 1 vial (2.5 ml)
Conjugate A dilution buffer – 1 vial (25.0 ml)
TMB substrate solution – 2 vials (30 ml each)
Wash buffer concentrate – 2 vials (50 ml each)
Stop reagent – 2 vials (30 ml each)
Plate sealing sheet – 10 pcs
Instructions for use – 1 pc
Quality control certificate (analytical passport) – 1 pc

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, HBsAg-ELISA Reagent Kit for Enzyme Immunoassay Detection of Hepatitis B Virus Surface Antigen in Human Serum (Plasma) According to TU 21.20.23-0092-18619450-2020, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.

Back